{"id":259536,"date":"2025-09-27T19:56:10","date_gmt":"2025-09-27T19:56:10","guid":{"rendered":"https:\/\/www.europesays.com\/us\/259536\/"},"modified":"2025-09-27T19:56:10","modified_gmt":"2025-09-27T19:56:10","slug":"walk-raises-awareness-for-stratham-2-year-old-with-rare-genetic-condition-boston-25-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/259536\/","title":{"rendered":"Walk raises awareness for Stratham 2-year-old with rare genetic condition \u2013 Boston 25 News"},"content":{"rendered":"<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">BOSTON  \u2014 The Children\u2019s Tumor Foundation is raising awareness about a group of incurable genetic conditions called neurofibromatosis, or NF. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Neurofibromatosis is a group of genetic conditions that causes tumors to grow on nerves throughout the body.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">The Children\u2019s Tumor Foundation held a \u2018Shine A Light Walk\u2019 around Jamaica Pond on Saturday and was joined by families dealing with NF. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Carly and Nino Esile travel frequently from Stratham, New Hampshire, to Boston Hospitals for their 2-year-old son, Johan.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Johan was diagnosed with a type of neurofibromatosis known as NF1 when he was four months old. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">\u201cHe is a curious little kid,\u201d said Johan\u2019s mother, Carly. \u201cHe\u2019s in that age where he wants to learn about everything, he loves dinosaurs and cars.\u201d<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Although NF1 is a genetic condition, no one in the Esile family has had it before.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">NF1 is considered rare, with 1 in 3,000 people being diagnosed.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">The family has spent the last year or so navigating the unknown. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">\u201cHe could develop kind of normally and live a pretty normal life or he could have severe learning challenges or severe physical pain or issues with mobility,\u201d explained Carly.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Currently, Johan is doing well. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">His neurofibromas, or non-cancerous tumors, are benign. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">\u201cWhat keeps you staying positive through this journey? What do you focus on?\u201d asked Boston 25\u2019s Alyssa Azzara.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">\u201cThe now,\u201d said Nino. \u201cI think my approach to this entire diagnosis is that there\u2019s really nothing we can do in the immediate future, and he\u2019s a happy little kid who\u2019s healthy.\u201d<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">As part of the walk, Johan and his family raised $10,000 for the Children\u2019s Tumor Foundation.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">The Director of Research at the Massachusetts General Hospital Neurofibromatosis Center, Vanessa Merker also attended the walk. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">\u201cWe recently were lucky enough to get two FDA-approved drugs thanks to the Children\u2019s Tumor Foundation,\u201d said Merker. \u201cThere\u2019s still a lot of progress to be made.\u201d<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">This is a developing story. Check back for updates as more information becomes available. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\"><b>Download the <\/b><a href=\"https:\/\/www.boston25news.com\/news\/local\/have-new-device-get-our-free-boston-25-news-weather-apps\/PDC6X7UKOFDBVPV5YJHG3CX36I\/\" target=\"_blank\" rel=\"noopener\"><b>FREE Boston 25 News app<\/b><\/a><b> for breaking news alerts.<\/b><\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph\">Follow Boston 25 News on <a href=\"https:\/\/www.facebook.com\/Boston25News\/\" target=\"_blank\" rel=\"noopener\">Facebook<\/a> and <a href=\"https:\/\/twitter.com\/boston25\" target=\"_blank\" rel=\"noopener\">Twitter<\/a>. | <a href=\"https:\/\/www.boston25news.com\/video\/live-stream\/\" target=\"_blank\" title=\"\" rel=\"noopener\">Watch Boston 25 News NOW<\/a><\/p>\n<p class=\"default__StyledText-sc-tl066j-0 fcApnw body-paragraph body-copyright\">\u00a92025 Cox Media Group<\/p>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"BOSTON \u2014 The Children\u2019s Tumor Foundation is raising awareness about a group of incurable genetic conditions called neurofibromatosis,&hellip;\n","protected":false},"author":3,"featured_media":259537,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[2731,136167,104,136166,136168,815,2739,73917,136169,159,136170,67,132,68],"class_list":{"0":"post-259536","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-boston","9":"tag-boston-25-news","10":"tag-breaking-news","11":"tag-breaking-story","12":"tag-childrens-tumor-foundation","13":"tag-genetics","14":"tag-massachusetts","15":"tag-neurofibromatosis","16":"tag-nf","17":"tag-science","18":"tag-shine-a-light-walk","19":"tag-united-states","20":"tag-unitedstates","21":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115278026380687531","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/259536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=259536"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/259536\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/259537"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=259536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=259536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=259536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}